跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8 条关于
“AviadoBio”
全部
8
临床试验
0
药物
0
机构
1
资讯
7
去年
Astellas and AviadoBio Partner in $2.2 Billion Deal to Advance Gene Therapy for Frontotemporal Dementia
去年
AviadoBio Completes Second Cohort in Phase 1/2 Trial for Frontotemporal Dementia Gene Therapy
11个月前
AviadoBio Secures $413M Option Deal for UGX-202 Optogenetics Gene Therapy to Restore Vision in Retinitis Pigmentosa
去年
Astellas and AviadoBio Partner on Gene Therapy for Frontotemporal Dementia in $2.18 Billion Deal
去年
AviadoBio and Astellas Forge $2.18 Billion Deal for Frontotemporal Dementia Gene Therapy
去年
Frontotemporal Dementia Therapeutics Enter New Era as Gene and Antibody Therapies Advance Toward Market
3年前
Novel Gene Therapies and Biomarkers Advance the Fight Against Frontotemporal Dementia